Rockwell Medical
Rockwell Medical is a Michigan-based biopharmaceutical company that develops and commercializes novel therapies for the treatment of iron deficiency and anemia.
Business Model:
Revenue: $68.8M
Employees: 201-500
Rankings
Industries / Tags:
Detailed Rockwell Medical Information
Geographic Data
Address: 30142 Wixom Road
City: Wixom
State: MI
Zip: 48393
Country: US
Financial Info
Stage:
post ipo equity
Raised Last:
$15M
Raised Total:$65M
Social
Metrics
9,512,304Website Global Rank
147Website Monthly Traffic
Twitter Followers
Description
Rockwell Medical is a Michigan-based biopharmaceutical company that develops and commercializes novel therapies for the treatment of iron deficiency and anemia.
Contact Phone:
+18004493353
Contact Email:
Rockwell Medical went public on 1/27/1998 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
1/27/1998
Ticker Symbol:
RMTI
IPO Price:
$4/share
Amount Raised:
$59M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 3/2020 | Debt | $22.5M |
Innovatus Capital Partners, LLC |
10/2018 | Equity | $22M | 6/2022 | Post-IPO Equity | $12M | 6/2022 | PIPE | $3M | 10/2014 | Post-IPO Equity | $15M | 6/2013 | Post-IPO Debt | 1 | $20M |
Hercules Capital Hercules Capital |
5/2022 | Post-IPO Equity | 1 | $15M |
Antara Capital Master Fund Antara Capital Master Fund |
4/2022 | Post-IPO Equity | 1 | $15M |
DaVita DaVita |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
